SuNam Co., Ltd. (KOSDAQ:294630)
4,015.00
+430.00 (11.99%)
At close: Apr 1, 2026
SuNam Revenue
In the year 2025, SuNam had annual revenue of 3.39B KRW with 140.92% growth. SuNam had revenue of 1.04B in the quarter ending December 31, 2025, with 106.89% growth.
Revenue
3.39B
Revenue Growth
+140.92%
P/S Ratio
22.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.39B | 1.98B | 140.92% |
| Dec 31, 2024 | 1.41B | -4.99B | -78.01% |
| Dec 31, 2023 | 6.39B | 26.30M | 0.41% |
| Dec 31, 2022 | 6.36B | 5.23B | 459.69% |
| Dec 31, 2021 | 1.14B | -267.31M | -19.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Creas F&C Co.,Ltd | 484.33B |
| Hyundai Industrial | 367.91B |
| Jeil M&S | 202.36B |
| Sinsin Pharmaceutical | 113.78B |
| Hwail Pharmaceutical | 107.87B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Korea Business News | 75.91B |
| Mr. Blue | 67.46B |